Medical Device News Magazine

HearUSA to Carry Sony’s Over-the-Counter Hearing Aids

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Responding to the Food and Drug Administration’s recent approval of over-the-counter (OTC) hearing aids, today HearUSA announced that it will offer Sony’s new over-the-counter hearing aids. The first two models of the over-the-counter hearing aids – the Sony CRE-C10 and Sony CRE-E10 – will be available for clients to purchase early next year in all HearUSA centers and online.

According to HearUSA President James Gilchrist, OTC hearing aids have the potential to increase the number of people who address their hearing loss by improving the overall awareness of the importance of hearing health; providing affordable access to hearing solutions for those with mild to moderate hearing loss; and empowering Americans to start their hearing health journey sooner.

Further, as a strong consumer brand, Sony will help shatter the stigma associated with hearing loss and guide more people towards better hearing health.

“Sony’s OTC hearing aids, built on their world-renowned leadership and experience in audio technology, will accelerate HearUSA’s new brand vision to bring the ‘Sound of the New Age’ to millions of new clients nationwide,” stated Gilchrist. “Sixty-five percent of the people in the United States with hearing loss do not wear hearing aids.[1] OTC hearing aids will help raise awareness about hearing health and engage more clients with an effective solution to start on the journey to better hearing health sooner – one to be guided by our hearing care professionals.”

The new Sony models – the CRE-C10 and the CRE-E10 – blend comfort and technology to reconnect consumers with mild to moderate hearing loss to what matters most[2].

HearUSA has developed a guided process to help clients discover whether they are a good candidate for OTC hearing aids based on their type and severity of hearing loss. HearUSA will educate clients on the importance of a comprehensive hearing aid evaluation and the role of hearing care professionals in diagnosing and improving their overall hearing health and wellness. Service packages will be available for OTC candidates that want the support of a hearing care professional on their hearing health journey.

Sony’s new OTC hearing aids will be available for purchase in early 2023 at HearUSA hearing centers nationally and online at the HearUSA website, where consumers will also be guided through a hearing screening and questionnaire to determine if OTC hearing aids are right for them.

“The addition of Sony’s OTC hearing aids to our already industry-leading portfolio of prescription solutions is as significant for our hearing care professionals as it is for our clients,” stated HearUSA’s Senior Director, Professional Development Sheneekra Adams, AuD. “The first step in a client’s hearing health journey should always begin with professional consultation. Now, thanks to this collaboration, our HCPs nationwide are equipped with a complete portfolio of the world’s best hearing aid solutions for all clients, across all levels of hearing loss and budget.”

The availability of the Sony models through HearUSA comes on the heels of the company’s launch of a bold new brand and brand vision – Sound of the New Age – dedicated to transforming the way hearing care is delivered in the United States.

For more information on HearUSA, visit www.hearusa.com.

[1] Quick Statistics About Hearing. (2021, March 25). www.nidcd.nih.gov. Retrieved October 11, 2022, from https://www.nidcd.nih.gov/health/statistics/quick-statistics-hearing

[2] Sony | Hearing control app – Use app on smartphone to personalize settings. Download app at Google Play and the App Store. Network services, content, and operating system and software subject to terms and conditions and may be changed, interrupted or discontinued at any time and may require registration.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”